Literature DB >> 16361586

Expanded motor and psychiatric phenotype in autosomal dominant Segawa syndrome due to GTP cyclohydrolase deficiency.

J L K Van Hove1, J Steyaert, G Matthijs, E Legius, P Theys, R Wevers, A Romstad, L B Møller, K Hedrich, D Goriounov, N Blau, C Klein, P Casaer.   

Abstract

BACKGROUND: Segawa syndrome due to GTP cyclohydrolase deficiency is an autosomal dominant disorder with variable expression, that is clinically characterised by l-dopa responsive, diurnally fluctuating dystonia and parkinsonian symptoms.
OBJECTIVE: To delineate the neurological and psychiatric phenotype in all affected individuals of three extended families.
METHODS: GTP cyclohydrolase deficiency was documented by biochemical analyses, enzymatic measurements in fibroblasts, and molecular investigations. All affected individuals were examined neurologically, and psychiatric data were systematically reviewed.
RESULTS: Eighteen affected patients from three families with proven GTP cyclohydrolase deficiency were identified. Eight patients presenting at less than 20 years of age had typical motor symptoms of dystonia with diurnal variation. Five family members had late-presenting mild dopa-responsive symptoms of rigidity, frequent falls, and tendonitis. Among mutation carriers older than 20 years of age, major depressive disorder, often recurrent, and obsessive-compulsive disorder were strikingly more frequent than observed in the general population. Patients responded well to medication increasing serotonergic neurotransmission and to l-dopa substitution. Sleep disorders including difficulty in sleep onset and maintenance, excessive sleepiness, and frequent disturbing nightmares were present in 55% of patients.
CONCLUSION: Physicians should be aware of this expanded phenotype in affected members of families with GTP cyclohydrolase deficiency.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16361586      PMCID: PMC2117403          DOI: 10.1136/jnnp.2004.051664

Source DB:  PubMed          Journal:  J Neurol Neurosurg Psychiatry        ISSN: 0022-3050            Impact factor:   10.154


  40 in total

Review 1.  Norepinephrine dysfunction in depression.

Authors:  A Anand; D S Charney
Journal:  J Clin Psychiatry       Date:  2000       Impact factor: 4.384

2.  Reduced nitric oxide metabolites in CSF of patients with tetrahydrobiopterin deficiency.

Authors:  Giovanna Zorzi; Beat Thöny; Nenad Blau
Journal:  J Neurochem       Date:  2002-01       Impact factor: 5.372

3.  Exon deletions in the GCHI gene in two of four Turkish families with dopa-responsive dystonia.

Authors:  C Klein; K Hedrich; K Kabakçi; K Mohrmann; K Wiegers; O Landt; J Hagenah; E Schwinger; P P Pramstaller; L J Ozelius; K Gucuyener; S Aysun; E Demir
Journal:  Neurology       Date:  2002-12-10       Impact factor: 9.910

4.  Faster sequential genetic linkage computations.

Authors:  R W Cottingham; R M Idury; A A Schäffer
Journal:  Am J Hum Genet       Date:  1993-07       Impact factor: 11.025

5.  Dopa-responsive dystonia and Tourette syndrome in a large Danish family.

Authors:  Anne Romstad; Erik Dupont; Bente Krag-Olsen; Karen Østergaard; Per Guldberg; Flemming Güttler
Journal:  Arch Neurol       Date:  2003-04

Review 6.  The epidemiology and cross-national presentation of obsessive-compulsive disorder.

Authors:  E Horwath; M M Weissman
Journal:  Psychiatr Clin North Am       Date:  2000-09

Review 7.  Role of norepinephrine in the pathophysiology and treatment of mood disorders.

Authors:  K J Ressler; C B Nemeroff
Journal:  Biol Psychiatry       Date:  1999-11-01       Impact factor: 13.382

Review 8.  Depression and antisocial personality disorder: two contrasting disorders of 5HT function.

Authors:  J F W Deakin
Journal:  J Neural Transm Suppl       Date:  2003

Review 9.  The role of noradrenaline and selective noradrenaline reuptake inhibition in depression.

Authors:  N Brunello; J Mendlewicz; S Kasper; B Leonard; S Montgomery; J Nelson; E Paykel; M Versiani; G Racagni
Journal:  Eur Neuropsychopharmacol       Date:  2002-10       Impact factor: 4.600

10.  The epidemiology of major depressive disorder: results from the National Comorbidity Survey Replication (NCS-R).

Authors:  Ronald C Kessler; Patricia Berglund; Olga Demler; Robert Jin; Doreen Koretz; Kathleen R Merikangas; A John Rush; Ellen E Walters; Philip S Wang
Journal:  JAMA       Date:  2003-06-18       Impact factor: 56.272

View more
  28 in total

Review 1.  Guanine triphosphate-cyclohydrolase 1-deficient dopa-responsive dystonia presenting as frequent falling in 2 children.

Authors:  Chang-Yong Tsao
Journal:  J Child Neurol       Date:  2011-11-08       Impact factor: 1.987

2.  Utility of MLPA in deletion analysis of GCH1 in dopa-responsive dystonia.

Authors:  Daniela Steinberger; Jutta Trübenbach; Birgit Zirn; Barbara Leube; Gabriele Wildhardt; Ulrich Müller
Journal:  Neurogenetics       Date:  2006-11-17       Impact factor: 2.660

3.  Sleep and rhythm consequences of a genetically induced loss of serotonin.

Authors:  Smaranda Leu-Semenescu; Isabelle Arnulf; Caroline Decaix; Fathi Moussa; Fabienne Clot; Camille Boniol; Yvan Touitou; Richard Levy; Marie Vidailhet; Emmanuel Roze
Journal:  Sleep       Date:  2010-03       Impact factor: 5.849

4.  Impaired sleep quality and restless legs syndrome in idiopathic focal dystonia: a controlled study.

Authors:  Sebastian Paus; Jennifer Gross; Martina Moll-Müller; Frank Hentschel; Annika Spottke; Bettina Wabbels; Thomas Klockgether; Michael Abele
Journal:  J Neurol       Date:  2011-04-16       Impact factor: 4.849

5.  Co-occurrence of affective and schizophrenia spectrum disorders with PINK1 mutations.

Authors:  Susanne Steinlechner; Jessica Stahlberg; Birgit Völkel; Ana Djarmati; Johann Hagenah; Anja Hiller; Katja Hedrich; Inke König; Christine Klein; Rebekka Lencer
Journal:  J Neurol Neurosurg Psychiatry       Date:  2007-01-03       Impact factor: 10.154

6.  Parkinson's disease in GTP cyclohydrolase 1 mutation carriers.

Authors:  Joanne Terbeek; Sylvia Hermans; Koen Van Laere; Wim Vandenberghe
Journal:  Brain       Date:  2014-11-28       Impact factor: 13.501

Review 7.  Nonmotor manifestations of dystonia: a systematic review.

Authors:  Daniel J Kuyper; Veronica Parra; Shanae Aerts; Michael S Okun; Benzi M Kluger
Journal:  Mov Disord       Date:  2011-04-11       Impact factor: 10.338

Review 8.  Dopa-responsive dystonia--clinical and genetic heterogeneity.

Authors:  Subhashie Wijemanne; Joseph Jankovic
Journal:  Nat Rev Neurol       Date:  2015-06-23       Impact factor: 42.937

9.  Neuropsychiatric symptoms and intelligence quotient in autosomal dominant Segawa disease.

Authors:  Eduardo López-Laso; Araceli Sánchez-Raya; Juan Antonio Moriana; Eduardo Martínez-Gual; Rafael Camino-León; María Elena Mateos-González; Juan Luis Pérez-Navero; Juan José Ochoa-Sepúlveda; Aida Ormazabal; Thomas Opladen; Christine Klein; José Ignacio Lao-Villadóniga; Katrin Beyer; Rafael Artuch
Journal:  J Neurol       Date:  2011-05-10       Impact factor: 4.849

10.  Study of a Swiss dopa-responsive dystonia family with a deletion in GCH1: redefining DYT14 as DYT5.

Authors:  C Wider; S Melquist; M Hauf; A Solida; S A Cobb; J M Kachergus; J Gass; K D Coon; M Baker; A Cannon; D A Stephan; D F Schorderet; J Ghika; P R Burkhard; G Kapatos; M Hutton; M J Farrer; Z K Wszolek; F J G Vingerhoets
Journal:  Neurology       Date:  2007-09-05       Impact factor: 9.910

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.